Table 2.
Descriptive profiles for significant cycles of HR, PR, RR and SpO2.
| Period | Period 1 | Period 2 | Period 3 | Period 4 | |
| Sampling | (0–3) | (4–6) | (7–13) | (14–21) | |
| n | 116 | 114 | 125 | 106 | |
| Eligible sample* | HR | 82 (70.7) | 64 (56.1) | 91 (72.8) | 67 (63.2) |
| PR | 101 (87.1) | 88 (77.2) | 106 (84.8) | 84 (79.2) | |
| RR | 99 (85.3) | 85 (74.6) | 104 (83.2) | 84 (79.2) | |
| SpO2 | 103 (88.8) | 89 (78.1) | 106 (84.8) | 85 (80.2) | |
| Significant cycle** | HR | 80 (98) | 64 (100) | 89 (98) | 67 (100) |
| PR | 100 (99) | 87 (99) | 104 (98.1) | 83 (99) | |
| RR | 90 (91) | 84 (99) | 97 (93.3) | 79 (94) | |
| SpO2 | 94 (91.3) | 86 (97) | 103 (97) | 78 (92) | |
| Circadian cycle*** | HR | 19 (23.8) | 11 (17.2) | 20 (22.5) | 13(19.4) |
| PR | 20 (20) | 16 (18.4) | 20 (19.2) | 16 (19.3) | |
| RR | 25 (27.8) | 28 (33.3) | 21 (21.6) | 11 (13.9) | |
| SpO2 | 15 (16) | 10 (11.6) | 17 (16.5) | 15 (19.2) |
Data are shown in n (%). Parentheses are percentages of * eligible samples in all samples, ** significant cycles in all eligible samples, and *** circadian cycles in significant cycles.